Synthetic Hemo-technologIEs to Locate and Disinfect (SHIELD)
Inactive
Contract Opportunity
Notice ID
HR001123S0037
Department/Ind. Agency
DEPT OF DEFENSE
Sub-tier
DEFENSE ADVANCED RESEARCH PROJECTS AGENCY (DARPA)
Office
DEF ADVANCED RESEARCH PROJECTS AGCY
Looking for contract opportunity help?
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
General Information
- Contract Opportunity Type: Presolicitation (Updated)
- Updated Published Date: Jul 25, 2023 02:41 pm EDT
- Original Published Date: Jun 28, 2023 03:11 pm EDT
- Updated Response Date: Sep 27, 2023 04:00 pm EDT
- Original Response Date: Sep 27, 2023 04:00 pm EDT
- Inactive Policy: Manual
- Updated Inactive Date: Oct 27, 2023
- Original Inactive Date: Oct 27, 2023
- Initiative:
- None
Classification
- Original Set Aside:
- Product Service Code: AC11 - NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; BASIC RESEARCH
- NAICS Code:
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Place of Performance:
Description
The Synthetic Hemo-technologIEs to Locate and Disinfect (SHIELD) program will develop safe and effective prophylactic countermeasures to defeat bloodborne pathogens and prevent bloodstream infections (BSI) associated with combat wounds. The program will develop prophylactic countermeasures effective against both bacteria and fungi, pathogens that are responsible for the vast majority of BSI. State-of-the-art countermeasures to manage BSI include antifungals and antibiotics which can be toxic, ineffective, and be administered in an untimely manner. SHIELD will develop safe and effective broad-spectrum prophylaxes that will protect recipients from bloodborne bacteria and fungi and prevent BSI for up to 144 h.
Attachments/Links
Contact Information
Contracting Office Address
- 675 NORTH RANDOLPH STREET
- ARLINGTON , VA 222032114
- USA
Primary Point of Contact
- BAA Coordinator
- SHIELD@darpa.mil
Secondary Point of Contact
History
- Oct 27, 2023 11:55 pm EDTPresolicitation (Updated)
- Jun 28, 2023 03:11 pm EDTPresolicitation (Original)